Commack, NYNCT02974647Now EnrollingIRB Ready

T Cell Lymphoma Clinical Trial in Commack, NY

Access cutting-edge t cell lymphoma treatment through this clinical trial at a research site in Commack. Study-provided care at no cost to qualified participants.

Sponsored by Memorial Sloan Kettering Cancer Center

Quick Self-Assessment

See if you qualify for this Commack location

Preparing your pre-screening questions...

Expert Care in Commack

Access t cell lymphoma specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related t cell lymphoma treatment provided free

Apply for This Commack Location

Check if you qualify for this t cell lymphoma clinical trial in Commack, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Commack

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Commack site if eligible
  4. 4Begin participation

About This T Cell Lymphoma Study in Commack

The purpose of this study is to test any good and bad effects of the study drug called ruxolitinib. Ruxolitinib works by blocking a protein called JAK. JAK works along with another protein called STAT and is important for survival of many T or NK-cell lymphomas. By blocking JAK, ruxolitinib may cause T or NK-cell lymphomas to shrink.

Sponsor: Memorial Sloan Kettering Cancer Center

Who Can Participate

Inclusion Criteria

Pathologically confirmed T or NK cell lymphoma at the enrolling institution. For CTCL, patients with stage IB disease or greater are eligible.
Relapse or refractory disease after at least 1 systemic therapy except for T-PLL, LGL, or T-cell Lymphoproliferative diseases with JAK2 fusion.
Untreated patients may be allowed after discussion with P.I.
Measurable disease defined by:
Lugano Classification for systemic lymphoma or
Atypical and or malignant lymphocytes quantifiable by flow cytometry or morphology in blood or bone marrow or
mSWAT \> 0 or Sezary count ≥ 1000 cells/μL for CTCL
Previous systemic anti-cancer therapy for T-cell lymphoma must have been discontinued at least 2 weeks prior to treatment.
Glucocorticoids aimed at controlling lymphoma-related symptoms are allowed as long as they are tapered down to 20mg or less by the time of ruxolitiib initiation
Topical steroids for CTCL are permitted

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Commack?

Yes, this clinical trial (NCT02974647) has an active research site in Commack, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

T Cell Lymphoma Treatment Options in Commack, NY

If you're searching for t cell lymphoma treatment options in Commack, NY, this clinical trial (NCT02974647) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Commack research site is actively enrolling participants for this clinical trial. You'll receive care from experienced t cell lymphoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all t cell lymphoma clinical trials near you to find additional studies recruiting in your area.

More Lymphoma Trials in Commack, NY

See all lymphoma clinical trials recruiting in Commack — not just this study.

Browse Lymphoma Trials in Commack

Ready to Join in Commack?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Commack, NY